DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

50 hedge funds and large institutions have $352M invested in Dicerna Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+13
Holders Change %
+35.14%
% of All Funds
1.14%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.11%
New
20
Increased
16
Reduced
6
Closed
6
Calls
$2.28M
Puts
–
Net Calls
+$2.28M
Net Calls Change
+$2.25M

Top Buyers

1
EC
EcoR1 Capital
California
$43.7M
2
CAM
Cormorant Asset Management
Massachusetts
$33M
3
RI
RTW Investments
New York
$44.1M
4
RCM
RA Capital Management
Massachusetts
$44.8M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
$17.8M

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
$0
2
6CM
683 Capital Management
New York
$4.97M
3
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$0
4
BCM
Bourgeon Capital Management
Connecticut
$0
5
BCM
Bridgeway Capital Management
Texas
$1.35M
Name Holding Trade Value Shares
Change 		Shares
Change %
EAM
51
Eventide Asset Management
Massachusetts
– -$2.17M -377,000 Closed
Connor, Clark & Lunn Investment Management (CC&L)
52
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$397K -68,975 Closed
BCM
53
Bourgeon Capital Management
Connecticut
– -$190K -33,000 Closed
VF
54
Virtu Financial
New York
– -$114K -19,861 Closed
ARTA
55
A.R.T. Advisors
New York
– -$101K -17,650 Closed
Group One Trading
56
Group One Trading
Illinois
– -$29K -5,000 Closed
1 2
3